Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sterol C-5 desaturase, primarily known as ERG3 in fungal species, is a critical enzyme within the ergosterol biosynthesis pathway responsible for introducing a double bond at the C-5 position of the sterol nucleus (UniProt: P32353). Ergosterol is an essential component of fungal cell membranes, performing functions similar to cholesterol in humans by regulating membrane fluidity, permeability, and the function of membrane-bound proteins (NCBI Gene: 855700). This enzyme is a significant target in antifungal research because its inhibition or dysfunction disrupts the production of ergosterol, leading to compromised cell membrane integrity and inhibited fungal growth. Interestingly, ERG3 is also a major player in antifungal resistance; mutations that inactivate ERG3 allow fungi to bypass the lethal accumulation of toxic sterols typically caused by azole drugs, which target the upstream enzyme ERG11 (PMID: 21633012). In humans, the orthologous enzyme is Sterol-C5-desaturase (SC5D), and its deficiency is linked to the rare metabolic disorder lathosterolosis, highlighting the need for high selectivity in antifungal drug design (UniProt: Q15884; PMID: 10430571). Consequently, Sterol C-5 desaturase represents both a vulnerability in fungal pathogens and a complex factor in the evolution of clinical drug resistance.
Inhibition of the C-5(6) desaturation of episterol to ergosta-5,7,24(28)-trien-3β-ol, leading to ergosterol depletion and accumulation of atypical sterols that disrupt membrane integrity.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sterol C-5 desaturase (ERG3) (ERG3).